Sam Zand, DO - Medicare Psychiatry in Las Vegas, NV

Sam Zand, DO is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Las Vegas, Nevada. He went to Touro Un Col Of Osteopathic Medicine, Henderson and graduated in 2014 and has 10 years of diverse experience with area of expertise as Psychiatry. He is a member of the group practice Anywhere Clinic Llc, Anywhere Clinic Llc, Anywhere Clinic Llc, Anywhere Clinic Llc and his current practice location is 2040 W Charleston Blvd, Suite 504, Las Vegas, Nevada. You can reach out to his office (for appointments etc.) via phone at (702) 671-5127.

Sam Zand is licensed to practice in Nevada (license number DO2222) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1528485570.

Contact Information

Sam Zand, DO
2040 W Charleston Blvd, Suite 504,
Las Vegas, NV 89102-2227
(702) 671-5127
Not Available



Physician's Profile

Full NameSam Zand
GenderMale
SpecialityPsychiatry
Experience10 Years
Location2040 W Charleston Blvd, Las Vegas, Nevada
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sam Zand attended and graduated from Touro Un Col Of Osteopathic Medicine, Henderson in 2014
  NPI Data:
  • NPI Number: 1528485570
  • Provider Enumeration Date: 03/27/2014
  • Last Update Date: 04/15/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 1557581352
  • Enrollment ID: I20170822003558

Medical Identifiers

Medical identifiers for Sam Zand such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1528485570NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry DO2222 (Nevada)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Anywhere Clinic Llc418399631723
Anywhere Clinic Llc418399631723
Anywhere Clinic Llc418399631723
Anywhere Clinic Llc418399631723

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sam Zand allows following entities to bill medicare on his behalf.
Entity NameRoberson Ltd
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1235309030
PECOS PAC ID: 6002994688
Enrollment ID: O20080422000901

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameOasis Counseling Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1336400951
PECOS PAC ID: 3971752684
Enrollment ID: O20121012000077

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameAnywhere Clinic Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1316460850
PECOS PAC ID: 4183996317
Enrollment ID: O20170822003489

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameTms Physician Services Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1881139913
PECOS PAC ID: 2567720113
Enrollment ID: O20180111001848

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameMedtrans Behavioral Nevada Casal Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245781160
PECOS PAC ID: 7810259165
Enrollment ID: O20180326001159

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameMedtrans
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871915892
PECOS PAC ID: 9739437815
Enrollment ID: O20180806002709

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameBauza Neuropsychiatry Center Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1912596685
PECOS PAC ID: 7618370040
Enrollment ID: O20210722003696

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Entity NameSuccess Tms Of Nevada Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1104597202
PECOS PAC ID: 0941691349
Enrollment ID: O20211220000205

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sam Zand is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sam Zand, DO
2040 W Charleston Blvd, Suite 504,
Las Vegas, NV 89102-2227

Ph: () -
Sam Zand, DO
2040 W Charleston Blvd, Suite 504,
Las Vegas, NV 89102-2227

Ph: (702) 671-5127

News Archive

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

Uroplasty prices underwritten public offering of common stock

Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.

JCTM established to advance new research toward clinical applications

The California Institute of Technology (Caltech) and the University of California, Los Angeles (UCLA) have announced the establishment of the Joint Center for Translational Medicine (JCTM), which will advance experimental research into clinical applications, including the diagnosis and therapy of diseases such as cancer.

Regulation of fat production is abnormal in obesity, shows study

Gut hormones play an important role in regulating fat production in the body. One key hormone, released a few hours after eating, turns off fat production by regulating gene expression in the liver, but this regulation is abnormal in obesity, researchers at the University of Illinois Urbana-Champaign found in a new study.

Read more News

› Verified 1 days ago


Psychiatry & Neurology Doctors in Las Vegas, NV

Dr. Ejine Okoroafor, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 5440 W Sahara Ave, Suite 202, Las Vegas, NV 89146
Phone: 914-426-7774    
Dr. Garet Jefferson Zaugg, D.O.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2020 Wellness Way Ste 300, Las Vegas, NV 89106
Phone: 702-432-2233    Fax: 702-800-5456
Dr. Muhammed A Hyder, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 2465 E Twain Ave, Las Vegas, NV 89121
Phone: 702-789-6201    Fax: 304-522-0686
Dr. Krista Linn Pinard, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 3016 W Charleston Blvd Ste 150, Las Vegas, NV 89102
Phone: 702-790-2701    
Gobinder S. Chopra, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 6410 Medical Center St Ste A100, Las Vegas, NV 89148
Phone: 702-796-8500    Fax: 702-796-8502
Eden Santiago Lee, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 3014 W Charleston Blvd Ste 130, Las Vegas, NV 89102
Phone: 702-671-6475    Fax: 702-671-6440
John Reitano, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 501 S Rancho Dr, Ste I62, Las Vegas, NV 89106
Phone: 702-897-7250    Fax: 702-706-4838

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.